Search | ValuTok

Ksh Dbmr added blog Networking
2026-03-06 06:55:35

Global Healthcare Preparedness Driving the Infectious Diseases Market
Comprehensive Outlook on Executive Summary Infectious Diseases Market Size and Share CAGR Value The global infectious diseases market size was valued at USD 21.70 billion in 2024 and is expected to reach USD 33.99 billion by 2032, at a CAGR of 5.77% during the forecast period The Infectious Diseases report includes a range of inhibitors as well as driving forces of the market which...

0 Comments 0 Shares 846 Views 0 Reviews

Please log in to like, share and comment!
Komal Galande added blog Causes
2026-03-27 04:49:41

Can Innovation Accelerate the Fight Against Malaria Worldwide?
Executive Summary Malaria Treatment Market Research: Share and Size Intelligence CAGR Value The expected CAGR of malaria treatment market is tend to be around 6.6% in the mentioned forecast period. The market value is USD 647.13 million in 2022, and it would grow upto USD 1079.07 million by 2030. The credible Malaria Treatment report has estimations of CAGR values, which are very...

0 Comments 0 Shares 283 Views 0 Reviews

Please log in to like, share and comment!
Komal Galande added blog Causes
2026-03-27 06:18:00

Can Point-of-Care Diagnostics Improve Healthcare Access in Africa?
Global Executive Summary Africa Point-Of-Care Diagnostics Market: Size, Share, and Forecast CAGR Value The Africa Point-Of-Care diagnostics market size was valued at USD 691.08 million in 2025 and is expected to reach USD 1,076.78 million by 2033, at a CAGR of 5.7% during the forecast period This Africa Point-Of-Care Diagnostics Market research report...

0 Comments 0 Shares 374 Views 0 Reviews

Please log in to like, share and comment!
KUMUD SINGH added blog Health
2026-03-30 10:22:44

RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%
According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...

0 Comments 0 Shares 160 Views 0 Reviews

Please log in to like, share and comment!